55
39
Growth Score
-29 pts
Heat Score
-12 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
518221
Amorphical is a pharmaceutical company that manufactures a unique form of calcium.
- Yosi Ben: Founder and CEO
Steven Eitan: CFO and VP of Business Strategy
About the Company
Amorphical is a pharmaceutical company that manufactures a form of calcium called amorphous calcium carbonate. The company's new calcium-based therapeutics is an effective tool for treating osteoporosis, hypoparathyroidism, and a range of other calcium-related diseases.
Amorphical was founded on 2004 and is headquartered in Ness-Ziona,
Israel.
